Juillerat, Pascal

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2016 | 2015 | 2014 | 2013 | 2012 | 2011

2016

Müller, Rebekka; Ziade, Farah; Pittet, Valérie; Fournier, Nicolas; Ezri, Jessica; Schoepfer, Alain; Schibli, Susanne; Spalinger, Johannes; Braegger, Christian; Nydegger, Andreas; Juillerat, Pascal; Tutuian, Radu; Wiest, Reiner; Müller, Christoph; Swiss IBD Cohort Study Group, . (2016). Quality of Life in Swiss Paediatric Inflammatory Bowel Disease Patients: Do Patients and Their Parents Experience Disease in the Same Way? Journal of Crohn's & Colitis, 10(3), pp. 269-276. Elsevier 10.1093/ecco-jcc/jjv199

Friedli, Bernhard Christoph; Brunner, Felix; Prost, Jean-Christophe; Bovet, Cédric; Kröll, Dino; Macpherson, Andrew; Juillerat, Pascal (2016). 7α-hydroxy-4-cholesten-3-one for Diagnosis and Management of Bile Acid Malabsorption: first year clinical experience. (Unpublished). In: SGG/SSG Annual Congress.

2015

Harbord, Marcus; Annese, Vito; Vavricka, Stephan R; Allez, Matthieu; Barreiro-de Acosta, Manuel; Boberg, Kirsten Muri; Burisch, Johan; De Vos, Martine; De Vries, Anne-Marie; Dick, Andrew D; Juillerat, Pascal; Karlsen, Tom H; Koutroubakis, Ioannis; Lakatos, Peter L; Orchard, Tim; Papay, Pavol; Raine, Tim; Reinshagen, Max; Thaci, Diamant; Tilg, Herbert; ... (2015). The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. Journal of Crohn's & Colitis, 10(3), pp. 239-254. Oxford University Press 10.1093/ecco-jcc/jjv213

Juillerat, Pascal (19 November 2015). Smoking: What's new? (Unpublished). In: Berner IBD Symposium. Bern. 19.11.2015.

Annese, Vito; Beaugerie, Laurent; Egan, Laurence; Biancone, Livia; Bolling, Claus; Brandts, Christian; Dierickx, Daan; Dummer, Reinhard; Fiorino, Gionata; Gornet, Jean Marc; Higgins, Peter; Katsanos, Konstantinos H; Nissen, Loes; Pellino, Gianluca; Rogler, Gerhard; Scaldaferri, Franco; Szymanska, Edyta; Eliakim, Rami; Juillerat, Pascal (2015). European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies. Journal of Crohn's & Colitis, 9(11), pp. 945-965. Oxford University Press 10.1093/ecco-jcc/jjv141

Ditisheim, Saskia; Fournier, Nicolas; Juillerat, Pascal; Pittet, Valerie; Michetti, Pierre; Gabay, Cem; Finckh, Axel; Swiss IBD Cohort, Study Group (2015). Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study. Inflammatory bowel diseases, 21(11), pp. 2598-2604. Lippincott Williams & Wilkins 10.1097/MIB.0000000000000548

Juillerat, Pascal (November 2015). Tabac et qualité de vie (Unpublished). In: 9 ème Congrès national de la Société Française de Tabacologie. Toulouse. 05.-06.11.2015.

Safroneeva, Ekaterina; Vavricka, S R; Fournier, N; Pittet, V; Peyrin-Biroulet, L; Straumann, A; Rogler, G; Schoepfer, A M; Juillerat, Pascal; Swiss IBD Cohort, Study Group (2015). Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease. Alimentary pharmacology & therapeutics, 42(8), pp. 977-989. Wiley-Blackwell 10.1111/apt.13363

Biedermann, Luc; Fournier, Nicolas; Misselwitz, Benjamin; Frei, Pascal; Zeitz, Jonas; Manser, Christine N; Pittet, Valerie; Juillerat, Pascal; von Känel, Roland; Friederich, Michael; Vavricka, Stephan R; Rogler, Gerhard (2015). High Rates of Smoking Especially in Female Crohn's Disease Patients and Low Use of Supportive Measures to Achieve Smoking Cessation--Data from the Swiss IBD Cohort Study. Journal of Crohn's & Colitis, 9(10), pp. 819-829. Oxford University Press 10.1093/ecco-jcc/jjv113

Juillerat, Pascal (October 2015). Swiss Perspectives in Gastroenterology (Unpublished). In: UEGW (United European Gastroenterology Week). Barcelona. October 2015.

Juillerat, Pascal (10 September 2015). Mehr Adenome – weniger Karzinome: Neuigkeiten beim kolorektalen Karzinom-Screening (Unpublished). In: Minisymposium zum Thema Darmkrebs. Bern. 10.09.2015.

Juillerat, Pascal (3 September 2015). Smoking, inflammatory bowel disease and microbiom (Unpublished). In: 15th Clinical Update Frei von Tabak – Vivre sans tabac. Bern. 03.09.2015.

Safroneeva, Ekaterina; Vavricka, S; Fournier, N; Seibold, Frank Werner; Mottet, C; Nydegger, A; Ezri, J; Straumann, A; Rogler, G; Schoepfer, A M; Juillerat, Pascal; Swiss IBD Cohort, Study Group (2015). Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients. Alimentary pharmacology & therapeutics, 42(5), pp. 540-548. Wiley-Blackwell 10.1111/apt.13307

Begon, Jacques; Juillerat, Pascal; Cornuz, Jacques; Clair, Carole (2015). [Smoking and digestive tract: a complex relationship. Part 2: Intestinal microblota and cigarette smoking]. Revue médicale suisse, 11(478), pp. 1304-1306. Médecine & Hygiène

Begon, Jacques; Juillerat, Pascal; Cornuz, Jacques; Clair, Carole (2015). [Smoking and digestive tract: a complex relationship. Part 1: Inflammatory bowel disease and cigarette smoking]. Revue médicale suisse, 11(478), pp. 1282-1287. Médecine & Hygiène

van der Woude, C J; Ardizzone, S; Bengtson, M B; Fiorino, G; Fraser, G; Katsanos, K; Kolacek, S; Juillerat, Pascal; Mulders, A G M G J; Pedersen, N; Selinger, C; Sebastian, S; Sturm, A; Zelinkova, Z; Magro, F (2015). The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. Journal of Crohn's & Colitis, 9(2), pp. 107-124. Oxford University Press 10.1093/ecco-jcc/jju006

Juillerat, Pascal; Peter, M; Macpherson, James; Slack, Emma; Patuto, Nicola; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (February 2015). Measurement of functional blocade of TNF-alpha by anti-TNF agents is a stronger predictor than trough levels and anti-drug antibodies: 2-year prospective clinical data (Unpublished). In: European Crohn’s and colitis organization congress (ECCO). Barcelona. Februar 2015.

Juillerat, Pascal; Sokol, Harry; Froehlich, Florian; Yajnik, Vijay; Beaugerie, Laurent; Lucci, Matthew; Burnand, Bernard; Macpherson, Andrew; Cosnes, Jacques; Korzenik, Joshua R. (2015). Factors Associated with Durable Response to Infliximab in Crohnʼs Disease 5 Years and Beyond: A Multicenter International Cohort. Inflammatory bowel diseases, 21(1), pp. 60-70. Lippincott Williams & Wilkins 10.1097/MIB.0000000000000225

Juillerat, Pascal (2015). P1557 Measurement of Funtional Blocade of TNF-alpha by anti-TNF Agents Is A Stronger Predictor Than Through Levels And Anti-Drug Antibodies: 3-Year Prospective Clinical Data (Unpublished). In: 23rd United European Gastroenterology Week (UEGW). Barcelona. 24.-28.10.2015.

Juillerat, Pascal; Andrew, Peter; Macpherson, James; Slack, Emma; Seibold, Frank Werner; Cahenzli, Julia; McCoy, Kathleen; Macpherson, Andrew (2015). Measurement of functional blocade of TNF-alpha by anti-TNF agents is a stronger predictor than trough levels and anti-drug antibodies: 2-year prospective clinical data. Gastroenterology, 148(4), pp. 850-1. Elsevier

2014

Juillerat, Pascal (7 November 2014). Rôle ambivalent du tabac dans les maladies inflammatoires intestinales : pathophysiologie et implication cliniques (Unpublished). In: Meeting de la société française de tabacologie. 07.11.2014.

Hiroz, Philippe; Vavricka, Stephan; Fournier, Nicolas; Safroneeva, Ekaterina; Pittet, Valérie; Rogler, Gerhard; Schöpfer, Alain; Juillerat, Pascal; Swiss Inflammatory Bowel Diseases Cohort Study Group, The (2014). Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease Cohort. Scandinavian journal of gastroenterology, 49(10), pp. 1207-1218. Informa Healthcare 10.3109/00365521.2014.946082

Schaffer, Thomas; Schoepfer, Alain M; Seibold, Frank Werner; Juillerat, Pascal; Swiss Inflammatory Bowel Diseases Cohort Study Group, The (2014). Serum ficolin-2 correlates worse than fecal calprotectin and CRP with endoscopic Crohn's disease activity. Journal of Crohn's & Colitis, 8(9), pp. 1125-1132. Oxford University Press 10.1016/j.crohns.2014.02.014

Maillard, Michel H; Bortolotti, Murielle; Vader, John-Paul; Mottet, Christian; Schöpfer, Alain; Gonvers, Jean-Jacques; Burnand, Bernard; Froehlich, Florian; Michetti, Pierre; Pittet, Valérie; Juillerat, Pascal; Tutuian, Radu; Swiss Inflammatory Bowel Diseases Cohort Study Group, The (2014). Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitis. Journal of Crohn's & Colitis, 8(8), pp. 825-834. Oxford University Press 10.1016/j.crohns.2013.12.026

Vietti Violi, Naïk; Schöpfer, Alain; Fournier, Nicolas; Guiu, Boris; Bize, Pierre; Denys, Alban; Juillerat, Pascal; Swiss Inflammatory Bowel Diseases Cohort Study Group, The (2014). Prevalence and clinical importance of mesenteric venous thrombosis in the Swiss Inflammatory Bowel Disease Cohort. American Journal of Roentgenology, 203(1), pp. 62-69. American Roentgen Ray Society 10.2214/AJR.13.12447

Kelstrup, Anne Mette; Juillerat, Pascal; Korzenik, Joshua (2014). The accuracy of self-reported medical history: A preliminary analysis of the promise of internet-based research in Inflammatory Bowel Diseases. Journal of Crohn's & Colitis, 8(5), pp. 349-356. Elsevier 10.1016/j.crohns.2013.09.012

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (May 2014). CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Gastroenterology, 146(5), p. 239. Elsevier

Brunner, Felix; Clair, Carole; Begré, Stefan; von Känel, Roland; Macpherson, Andrew; Juillerat, Pascal; Swiss IBD Cohort Study Group, The (May 2014). Alcohol Consumption within the Swiss IBD Cohort Study. Gastroenterology, 146(5), pp. 776-777. Elsevier

Juillerat, Pascal (13 February 2014). Colitis ulcerosa. In: ETH Zürich Hönggerberg, Pharmakoklinik Fortbildung 23. Pharmathemen. Zürich. 13.02.2014.

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, J; Slack, Emma; Patuto, Nicola; Cahenzli, Julia; McCoy, Kathleen; Macpherson, Andrew (February 2014). CD62L (L-selectin) shedding for assessment of functional blockade of TNF alpha in anti-TNF treated IBD patients: clinical feasibility and perspectives (DOP060). Journal of Crohn's & Colitis, 8(Suppl1), pp. 43-44. Elsevier 10.1016/S1873-9946(14)60085-4

Protic, Marijana; Seibold, Frank Werner; Schöpfer, Alain; Radojicic, Zoran; Juillerat, Pascal; Bojic, Daniela; Mwinyi, Jessica; Mottet, Christian; Jojic, Njegica; Beglinger, Christoph; Vavricka, Stephan; Rogler, Gerhard; Frei, Pascal (2014). The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients. Journal of Crohn's & Colitis, 8(11), pp. 1427-1437. Elsevier 10.1016/j.crohns.2014.05.004

Juillerat, Pascal; Korzenik., JR (2014). Novel Nonbiologic Therapies for Ulcerative Colitis. In: Lichtenstein, Gary R. (ed.) Medical Therapy of Ulcerative Colitis (pp. 221-235). New York: Springer Science & Business Media 2014 10.1007/978-1-4939-1677-1_19

Juillerat, Pascal (2014). Upper GI bleeding. In: Vavricka, Stephan; Wilhelmi, Martin (eds.) Swiss Essentials in Gastroenterology 3rd Edition (pp. 58-61). online-Publikation: Swissgastroenterology

Brunner, Felix; Clair, C; Begré, Stefan; von Känel, Roland; Macpherson, Andrew; Juillerat, Pascal (2014). Alcohol Consumption within the Swiss IBD Cohort Study (P644). Journal of Crohn's & Colitis, 8(Suppl1), S339-S339. Elsevier 10.1016/S1873-9946(14)60764-9

Juillerat, Pascal; Sokol, H; Froehlich, F; Burnand, B; Yajnik, V; Beaugerie, L; Macpherson, Andrew; Cosnes, J; Korzenik, JR (2014). Facteurs associés à une réponse à l’infliximab prolongée au-delà de 5 ans : une étude de cohorte multi-centrique internationale (Unpublished). In: Journées Francophones d’Hépatologie-gastroentérologie et d’Oncologie Digestives. Paris.

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, F.; McCoy, Kathleen; Macpherson, Andrew (2014). CD62L (L-selectin) shedding for assessment of functional blockade of TNF alpha in anti-TNF treated IBD patients: clinical feasibility and perspectives. United European Gastroenterology Journal, 2(1suppl), A45-A46. Sage

Brunner, Felix; von Känel, Roland; Begré, Stefan; Willi, CC; Macpherson, Andrew; Juillerat, Pascal (2014). Prevalence of alcohol consumption and its influence on disease course in Swiss IBD patients. United European Gastroenterology Journal, 2(Suppl1), A365-A365.

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (2014). CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Swiss medical weekly, 144(Suppl206), 3S-3S. EMH Schweizerischer �rzteverlag

Brunner, Felix; von Känel, Roland; Begré, Stefan; Willi, C.C.; Macpherson, Andrew; Juillerat, Pascal (2014). Alcohol Consumption in Swiss IBD Patients: Prevalence and Influence on Disease Course. Swiss medical weekly, 144(Suppl206), 2S-2S. EMH Schweizerischer �rzteverlag

Juillerat, Pascal (2014). Mid GI bleeding. In: Vavricka, Stephan; Wilhelmi, Martin (eds.) Swiss Essentials in Gastroenterology 3rd Edition (p. 130). online-Publikation: Swissgastroenterology

Juillerat, Pascal (2014). Lower GI bleeding. In: Vavricka, Stephan; Wilhelmi, Martin (eds.) Swiss Essentials in Gastroenterology 3rd Edition (p. 131). online-Publikation: Swissgastroenterology

Juillerat, Pascal (2014). Varices. In: Vavricka, Stephan; Wilhelmi, Martin (eds.) Swiss Essentials in Gastroenterology 3rd Edition (pp. 44-46). online-Publikation: Swissgastroenterology

Juillerat, Pascal (2014). Linton tube. In: Vavricka, Stephan; Wilhelmi, Martin (eds.) Swiss Essentials in Gastroenterology 3rd Edition (p. 47). online-Publikation: Swissgastroenterology

Juillerat, Pascal (2014). TIPS. In: Vavricka, Stephan; Wilhelmi, Martin (eds.) Swiss Essentials in Gastroenterology 3rd Edition (pp. 202-203). online-Publikation: Swissgastroenterology

Juillerat, Pascal (2014). Corrosive Injury. In: Vavricka, Stephan; Wilhelmi, Martin (eds.) Swiss Essentials in Gastroenterology 3rd Edition (pp. 47-49). online-Publikation: Swissgastroenterology

Juillerat, Pascal (2014). OTSC® (Over The Scope Clip) ovesco. In: Vavricka, Stephan; Wilhelmi, Martin (eds.) Swiss Essentials in Gastroenterology 3rd Edition (p. 15). online-Publikation: Swissgastroenterology

Juillerat, Pascal (2014). Interventional Endoscopy. SEMS (Self Expanding Metal Stents). In: Vavricka, Stephan; Wilhelmi, Martin (eds.) Swiss Essentials in Gastroenterology 3rd Edition (p. 16). online-Publikation: Swissgastroenterology

Juillerat, Pascal (2014). Acute liver failure. In: Vavricka, Stephan; Wilhelmi, Martin (eds.) Swiss Essentials in Gastroenterology 3rd Edition (p. 206). online-Publikation: Swissgastroenterology

Juillerat, Pascal (2014). Ogilvie Syndrome. In: Vavricka, Stephan; Wilhelmi, Martin (eds.) Swiss Essentials in Gastroenterology 3rd Edition (pp. 148-149). onlin-Publikation: Swissgastroenterology

2013

Juillerat, Pascal; Sokol, H.; Yajnik, V.; Froehlich, F.; Beaugerie, L.; Cosnes, J.; Burnand, B.; Macpherson, Andrew; Korzenik, J.R. (October 2013). Factors associated with durable response to infliximab 5 years and beyond: a multi center international cohort. United European Gastroenterology Journal, 1(1 Suppl), i-i. 10.1177/2050640613505034

Juillerat, Pascal (19 September 2013). IBD and smoking (Unpublished). In: Colloque de tabacologie. CHUV, Lausanne. 19.09.2013.

Juillerat, Pascal (19 September 2013). IBD and smoking: update (Unpublished). In: IBD forum Gastroenterologie. CHUV, Lausanne. 19.09.2013.

Juillerat, Pascal (18 June 2013). Einfluss von Umweltfaktoren auf chronisch entzündliche Darmerkrankungen (Unpublished). In: SMCCV Informationsveranstaltung,. Bern. 18.06.2013.

Luong Ba, Kim; Juillerat, Pascal; Ducommun, Julien (2013). L’hépatite auto-immune. Revue médicale suisse, 9(382), pp. 831-835. Groupe Médecine & Hygiène

Juillerat, Pascal (9 April 2013). Chronisch Entzündliche Darmerkrankungen (Unpublished). In: Allgemeine Innere Medizin Weiterbildung. Inselspital Bern. 09.04.2013.

Juillerat, Pascal; Wasan, Sharmeel K.; Fowler, Sharyle A.; Friedman, Sonia; Pabby, Vikas K.; Coukas, Jennifer A.; Barto, Amy E.; Pellish, Randall; Germansky, Katharine A.; Cheifetz, Adam S.; Korzenik, Joshua R.; Farraye, Francis A.; Yajnik, Vijay (2013). Efficacy and Safety of Natalizumab in Crohn’s Disease Patients Treated at 6 Boston Academic Hospitals. Inflammatory bowel diseases, 19(11), pp. 2457-2463. Lippincott Williams & Wilkins 10.1097/MIB.0b013e3182a32a0d

Juillerat, Pascal; Sokol, Harry; Fowler, Sharyle A.; Froehlich, Florian; Vader, John-Paul; Yajnik, Vijay; Beaugerie, Laurent; Macpherson, Andrew J.; Cosnes, Jacques; Korzenik, Joshua R. (2013). 950 Factors associated with durable response to infliximab 5 years and beyond: a multi center international cohort. Gastroenterology, 144(5, Suppl. 1), p. 172. Elsevier

2012

Cámara, Rafael J A; Juillerat, Pascal; Pittet, Valérie; Schoepfer, Alain M; Begré, Stefan; von Känel, Roland; and the Swiss Inflammatory Bowel Disease Cohort Study Group, (2012). QUALITY OF LIFE: A POTENTIALLY USEFUL MEASURE TO INDICATE SUBCLINICAL FLARES IN CROHN'S DISEASE. Internal medicine journal, 42(7), e145-51. Sydney: Blackwell 10.1111/j.1445-5994.2011.02472.x

Juillerat, P; Schneeweiss, S; Cook, E F; Ananthakrishnan, A N; Mogun, H; Korzenik, J R (2012). Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease. Alimentary pharmacology & therapeutics, 36(3), pp. 239-47. Oxford: Wiley-Blackwell 10.1111/j.1365-2036.2012.05173.x

Mwinyi, Jessica; Grete-Wenger, Christa; Eloranta, Jyrki J.; Kullak-Ublick, Gerd A. (2012). The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course. PPAR Research, 2012, p. 349469. New York, N.Y.: Hindawi Publishing Corporation 10.1155/2012/349469

Furger, P; Collaborators, (2012). gastro-entérologie [Textbook] . Basel: Editions D&F GmbH

Juillerat, P; Wasan, SK; Fowler, SA; Yajnik, V; Korzenik, JR; Pabby, VK; Friedman, S; Coukos, JA; Barto, AE; Pellish, R; and Farraye, FA (2012). Efficacy and Safety of Natalizumab in Crohn’s Disease Patients Treated at 5 Academic Hospitals. Journal of Crohn's & Colitis, 6(Supplement 1), p. 128. Amsterdam: Elsevier

Juillerat, Pascal; Fowler, Sharyle; Yajnik, Vijay; R.Korzenik, Joshua (2012). CHARACTERISTICS OF PATIENTS WITH DURABLE USE OF INFLIXIMAB FOR > 5 YEARS. Gut, 2012 London: BMJ Publishing Group

Juillerat, Pascal; Fowler, Sharyle; Yajnik, Vijay; R.Korzenik, Joshua (2012). CHARACTERISTICS OF PATIENTS WITH DURABLE USE OF INFLIXIMAB FOR > 5 YEARS. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 2012 Basel: EMH Editores Medicorum Helveticorum

Juillerat, P (2012). Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. ECCO news, 7(1) Wien: European Crohn's and Colitis Organisation ECCO

2011

Ananthakrishnan, Ashwin N; Hur, Chin; Juillerat, Pascal; Korzenik, Joshua R (2011). Strategies for the prevention of postoperative recurrence in Crohn's disease: results of a decision analysis. American journal of gastroenterology, 106(11), pp. 2009-17. New York, N.Y.: Nature 10.1038/ajg.2011.237

von Ballmoos, Moritz Wyler; Haring, Bernhard; Juillerat, Pascal; Alkadhi, Hatem (2011). Meta-analysis: diagnostic performance of low-radiation-dose coronary computed tomography angiography. Annals of internal medicine, 154(6), pp. 413-20. Philadelphia, Pa.: American College of Physicians 10.1059/0003-4819-154-6-201103150-00007

Juillerat, P; Schneeweiss, S; Mogun, H; Cook, EF; Ananthakrishnan, AN; Korzenik, JR (2011). New H2-eceptor Antagonist Use May Increase Risk of Surgery or Hospitalization in Crohn's Disease While PPI Use May Be Associated With Ulcerative Colitis Flares. Differential Effects of Acid Suppressing Agents in IBD. In: Digestive Disease Week.

Juillerat, P; Schneeweiss, S; Cook, F; Ananthakrishnan, A; Mogun, H; Korzenik, J (2011). Gastric Acid Inhibiting Medications May Alter The Course Of Inflammatory Bowel Disease. In: 19th United European Gastroenterology Week (UEGW). Stockholm, Sweden. October 22-26, 2011.

Provide Feedback